Dr. Ciacci treated the first patient in a new safety trial testing stem cell injections for spinal cord injury paralysis. The procedure took place two years ago, and uses stem cells from fetal spinal cords to replace the lost or severed nerve connections.
The injections were successful in animal models and physicians hope human patients will be able to walk again after treatment.
More articles on spine surgery:
MIS laminectomy for spinal stenosis—Does spondylolisthesis impact outcomes? 5 key notes
The PPACA turns 5: Has it done more harm than good?
What impacts spine surgery malpractice claims more—Mortality or hospital costs?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.